__symbol__ Stock Quote Price and Forecast | CNN
View Hims & Hers Health, Inc. Class A HIMS stock quote prices, financial information, real-time forecasts, and company news from CNN.
www.cnn.comHere are the latest notable points on Hims & Hers Health (HIMS) stock as of mid-May 2026:
-
Recent earnings and guidance: HIMS reported Q1 2026 results with revenue around $608 million but a larger-than-expected non-GAAP loss, which pressured the stock in the near term. Management guided for roughly $690 million in revenue at the midpoint for the next quarter, indicating buoyant demand but ongoing profitability concerns. This mixed setup has kept investors focused on margins and cost control versus growth.[1][2]
-
Growth initiatives and risks: The company’s GLP-1 weight-loss strategy and the Novo Nordisk collaboration are viewed by some investors as potential long-term upside that could expand addressable markets and support subscriber growth. However, profitability pressures from higher SG&A and investment in international expansion remain a near-term headwind, contributing to volatility in HIMS shares.[1]
-
Market context and performance: Broadly, HIMS’s stock has traded with sensitivity to earnings misses and margin trajectories. Recent analyses note that while revenue growth remains fairly robust, the path to sustainable profitability is a key question for investors, with several outlets highlighting the impact of costs tied to GLP-1 initiatives and international growth on margins.[2][8]
-
Price action and current stance: Short-term price moves have reflected earnings timing and guidance versus the growth narrative. Some sources have noted declines following disappointing quarters, while others pointed to the strength of the top-line trajectory and higher revenue guidance as reasons for potential optimism at the next earningsPrint. Analysts’ sentiment remains mixed, with debates around value versus growth depending on margin recovery assumptions.[8][2]
-
Additional sources and ongoing coverage: For real-time quotes, detailed price history, and the latest newsroom updates, you can check major financial portals and the company’s investor relations site. MarketBeat and Stock Analysis are among outlets frequently updating HIMS coverage with earnings context and broker commentary.[2][8][1]
If you’d like, I can pull a current price chart, summarize analyst ratings, or fetch the most recent quarter’s exact numbers and guidance figures from the official reports. I can also create a quick chart comparing revenue, net income, and operating margin over the past four quarters to illustrate the profitability trend. Just tell me which format you prefer.
Citations:
- MarketBeat coverage of HIMS earnings and guidance.[1]
- Stock Analysis overview and recent Q1 context.[2]
- TradingView/other coverage notes on price action and guidance context.[3]